Səhifə 1 dan 19 nəticələr
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to diagnosis of heart disease, and specifically relates to diagnosis of cardiac ischemia by detecting levels of free fatty acids in serum using a fluorescently-modified free fatty acid binding protein.
2. Description of the
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to diagnosis of heart disease, and specifically relates to diagnosis of cardiac ischemia by detecting levels of free fatty acids in serum using a fluorescently-modified free fatty acid binding protein.
2. Description of the
FIELD OF INVENTION
This invention pertains to in vitro diagnostic devices using electrochemical detection of an analyte. In particular, this invention uses redox reactions, as revealed by amperometric and potentiometric measurements in all forms (coulometry, voltammetry, ion selective electrode,
FIELD OF THE INVENTION
The present invention relates to rapid methods for the detection of ischemic states and to kits for use in such methods. More particularly, the invention relates to the measurement of a bound specific transition element to human serum albumin or the measurement of albumin
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to rapid methods for the detection of ischemic states and to kits for use in such methods. More particularly, the invention relates to the measurement of a bound specific transition element to human serum albumin or
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to rapid methods for the detection of ischemic states and to kits for use in such methods. More particularly, the invention relates to the measurement of a bound specific transition element to human serum albumin or
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the U.S. National Phase of International Patent Application No. PCT/GB2007/003362, filed Sep. 7, 2007, which was published in English as WO 2008/029145 on Mar. 13, 2008, and claims priority under 35 U.S.C. .sctn.119 to Great Britain Patent
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a rapid method for the detection of ischemic states and to a kit for use in such a method. More particularly, the invention relates to the measurement of a bound specific transition element to human serum to
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a rapid method for the detection of ischemic states and to a kit for use in such a method. More particularly, the invention relates to the measurement of a bound specific transition element to human serum to
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a marker for detecting and measuring free radical damage; a method for the direct detection and measurement of the damaging activity of free radicals in vivo is provided.
2. Discussion of the Background
Free
FIELD OF THE INVENTION
The present invention generally relates to antioxidants which are biomedically applicable. More particularly, the present invention relates to the oxy-radical scavenging properties of protein- or peptide-bound bilirubins.
BACKGROUND OF THE INVENTION
Bilirubins are breakdown
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention is related to drug compounds or compositions,which are useful as allosteric modifiers of hemoglobin and, more particularly, the invention is directed to the use of certain drug compounds or drug compositions that are effective in
FIELD OF THE INVENTION
This invention relates to the use of nitroxide-labelled macromolecules, including hemoglobin, albumin, immunoglobulins and liposomes, to alleviate the toxic effects of oxygen-related species in a living organism and for the diagnosis and treatment of certain physiological
FIELD OF THE INVENTION
This invention relates to the combined use of membrane permeable nitroxide and membrane impermeable nitroxide in including nitroxide-labelled macromolecules, including polypeptide e.g., hemoglobin, albumin, immunoglobulins, polysacharide, e.g., dextran, hydroxylethyl starch
FIELD OF THE INVENTION
This invention relates to the combined use of membrane permeable nitroxide and membrane impermeable nitroxide in including nitroxide-labelled macromolecules, including polypeptide e.g., hemoglobin, albumin, immunoglobulins, polysacharide, e.g., dextran, hydroxylethyl starch